Jaguar Health to Present at H.C. Wainwright Global Investment Conference

Jaguar Health, Inc. has announced that its founder, president, and CEO, Lisa Conte, will present virtually at the H.C. Wainwright 27th Annual Global Investment Conference. The event is scheduled for September 8-10, 2025, offering updates on the company's near-term catalysts.

The presentation will be available on-demand starting at 7:00 AM Eastern, September 5, 2025. The conference can be attended both online and in-person at the Lotte New York Palace in New York City.

Jaguar Health focuses on developing pharmaceutical products derived from rainforest plants. Its subsidiary, Napo Pharmaceuticals, targets essential supportive care for gastrointestinal distress with FDA-approved drugs like Mytesi®. Another branch, Napo Therapeutics, aims at expanding access to these treatments in Europe.